Table: begin end state 1 37 cytoplasmic 38 60 transmembrane 61 65 non-cytoplasmic 66 89 transmembrane 90 108 cytoplasmic 109 133 transmembrane 134 174 non-cytoplasmic 175 194 transmembrane 195 200 cytoplasmic 201 223 transmembrane 224 244 non-cytoplasmic 245 265 transmembrane 266 281 cytoplasmic 282 305 transmembrane 306 326 non-cytoplasmic 327 350 transmembrane 351 380 cytoplasmic 381 400 transmembrane 401 405 non-cytoplasmic 406 426 transmembrane 427 437 cytoplasmic 438 457 transmembrane 458 462 non-cytoplasmic 463 482 transmembrane 483 492 cytoplasmic
Input: >N515DRAFT_2924 FitnessBrowser__Dyella79:N515DRAFT_2924 MLKNLFATTQISPASADLPGGGAHGEATLKRALTARHLVLLGIGAIIGAGIFVITGQAAA EHAGPAIVLSFVFAGIACALAALCYAEFAAMLPVSGSAYSYSYATLGEYVAWFVGWSLVL EYLFTVATVAAGWSGYFNKLLALISGWIGHDVSLPQTLAAAPFTVVDGHIQATGMFINLP AVAIIAAITGLCYVGITQSAFVNSIIVAIKVTVILLFIAFATKYINPDNWHPFIPASEGA SKYGWAGVGRAAAIVFFSYIGFDAVSTAAGEAKNPQRDMPIGIIGSLILCTILYIIVAGI LTGIADFRLLGTPEPVSTALDNYPSLHWLQIIVVIGAVTGLSSVMLVMLMGQPRIFYSMA RDGLIPAVFGRIHQKFRTPHVGTVVVGVLAAALGGLFNIGVLGEMVAMGTLLAFATVCIG VLVLRYTRPELPRAFRVPVPWIVCPLGALACMALFLQSFLEHWRWMLAWIAIGQAIYFLY GYSHSKLRKPAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server